These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14706212)

  • 1. Does early treatment of ocular myasthenia gravis with prednisone reduce progression to generalized disease?
    Kupersmith MJ
    J Neurol Sci; 2004 Feb; 217(2):123-4. PubMed ID: 14706212
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of prednisone on the progression from ocular to generalized myasthenia gravis.
    Monsul NT; Patwa HS; Knorr AM; Lesser RL; Goldstein JM
    J Neurol Sci; 2004 Feb; 217(2):131-3. PubMed ID: 14706214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of generalized disease at 2 years in patients with ocular myasthenia gravis.
    Kupersmith MJ; Latkany R; Homel P
    Arch Neurol; 2003 Feb; 60(2):243-8. PubMed ID: 12580710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease associated with myasthenia gravis. A report of 4 cases.
    Levin N; Karussis D; Abramsky O
    J Neurol; 2003 Jun; 250(6):766-7. PubMed ID: 12862037
    [No Abstract]   [Full Text] [Related]  

  • 5. Myasthenia gravis.
    Murray KB
    Kans Med; 1990 Jun; 91(6):181-3. PubMed ID: 2398638
    [No Abstract]   [Full Text] [Related]  

  • 6. Unusual case of recurrent falls: myasthenia gravis in an elderly patient.
    Alaama T; Basharat P; Nicolle MW
    Can Fam Physician; 2012 Nov; 58(11):1231-2. PubMed ID: 23152461
    [No Abstract]   [Full Text] [Related]  

  • 7. Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment.
    Kupersmith MJ; Ying G
    Br J Ophthalmol; 2005 Oct; 89(10):1330-4. PubMed ID: 16170126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab in the management of refractory myasthenia gravis.
    Zebardast N; Patwa HS; Novella SP; Goldstein JM
    Muscle Nerve; 2010 Mar; 41(3):375-8. PubMed ID: 19852027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myasthenia gravis and return to flying status.
    Karmon Y; Blum S; Levite R; Barenboim E; Gadoth N
    Aviat Space Environ Med; 2010 Jan; 81(1):69-73. PubMed ID: 20058740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus Improves Symptoms of Children With Myasthenia Gravis Refractory to Prednisone.
    Liu C; Gui M; Cao Y; Lin J; Li Y; Ji S; Bu B
    Pediatr Neurol; 2017 Dec; 77():42-47. PubMed ID: 29074055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug therapy in myasthenia gravis].
    Aarli JA
    Tidsskr Nor Laegeforen; 1976 Dec; 96(34-36):1803-5. PubMed ID: 189451
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of early prednisolone treatment on the generalization rate in ocular myasthenia gravis.
    Zach H; Cetin H; Hilger E; Paul A; Wuschitz B; Jung R; Auff E; Zimprich F
    Eur J Neurol; 2013 Apr; 20(4):708-13. PubMed ID: 23279780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cigarette Smoking and Activities of Daily Living in Ocular Myasthenia Gravis.
    Gratton SM; Herro AM; Feuer WJ; Lam BL
    J Neuroophthalmol; 2016 Mar; 36(1):37-40. PubMed ID: 26457691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis.
    Pasnoor M; He J; Herbelin L; Burns TM; Nations S; Bril V; Wang AK; Elsheikh BH; Kissel JT; Saperstein D; Shaibani JA; Jackson C; Swenson A; Howard JF; Goyal N; David W; Wicklund M; Pulley M; Becker M; Mozaffar T; Benatar M; Pazcuzzi R; Simpson E; Rosenfeld J; Dimachkie MM; Statland JM; Barohn RJ;
    Neurology; 2016 Jul; 87(1):57-64. PubMed ID: 27306628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ocular myasthenia: clinical course and strategies for treatment].
    Marzo ME; Pérez López-Fraile I; Capablo JL; Ara JR; Usón M
    Rev Neurol; 1998 Mar; 26(151):398-400. PubMed ID: 9585951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital myasthenia gravis. The clinical spectrum. A practical approach to diagnosis and treatment.
    Dooley JM; Writer H; Gibson EJ; MacSween J
    Clin Pediatr (Phila); 1988 Dec; 27(12):575-8. PubMed ID: 3191649
    [No Abstract]   [Full Text] [Related]  

  • 17. Dermatomyositis and myastenia gravis: An uncommon association with therapeutic implications.
    Sangüesa Gómez C; Flores Robles BJ; Méndez Perles C; Barbadillo C; Godoy H; Andréu JL
    Reumatol Clin; 2015; 11(4):244-6. PubMed ID: 25498320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myasthenia gravis and monoclonal IgG gammopathy.
    Somer H; Pirskanen R; Lefvert AK; Wasastjerna C; Konttinen A
    Neurology; 1979 Jun; 29(6):842-7. PubMed ID: 109788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastasizing thymoma and myasthenia gravis. Favorable response to glucocorticoids after failed chemotherapy and radiation therapy.
    Tandan R; Taylor R; DiCostanzo DP; Sharma K; Fries T; Roberts J
    Cancer; 1990 Mar; 65(6):1286-90. PubMed ID: 2407333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis for the effect of different regimens on ocular myasthenia gravis in children].
    Liu C; Wang X; Xie L; Peng J; Wu L; Zheng X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Nov; 42(11):1275-1279. PubMed ID: 29187654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.